Aclaris Therapeutics, Inc. (ACRS) Discusses ATI-052 Proof-of-Concept Results in Atopic Dermatitis and Asthma - Slideshow

2026-10-29. The following slide deck was published by Aclaris Therapeutics, Inc.

CryptoAlerta — análise de criptomoedas e mercado em tempo real